Upventa Biosciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 1 Year 10 Months
About Upventa Biosciences
Upventa Biosciences Private Limited (UBPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 March 2023 (One year and ten months 29 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Paper Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Uma Sethi, Alok Saxena, and Nitin Bhasin serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U21003DL2023PTC411696
- Company No.
411696
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Mar 2023
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Upventa Biosciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Uma Sethi  | Director | 28-Mar-2023 | Current |
| Alok Saxena | Director | 28-Mar-2023 | Current |
| Nitin Bhasin | Director | 28-Mar-2023 | Current |
Financial Performance of Upventa Biosciences.
Enhance accessibility to Upventa Biosciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Upventa Biosciences?
Unlock access to Upventa Biosciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Upventa Research & Analytics Private LimitedUma Sethi, Alok Saxena and 1 more are mutual person
- Upventa Koncepts Private Limited
Uma Sethi is a mutual person
- Cyclook Techies Private Limited
Uma Sethi and Nitin Bhasin are mutual person
- Jai Balaji Datamatics Private Limited
Alok Saxena is a mutual person
- Nichegen Healthcare Private Limited
Nitin Bhasin is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Upventa Biosciences?
Unlock and access historical data on people associated with Upventa Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Upventa Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Upventa Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.